| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/01/2004 | EP0969867B1 Use of anti-il-12 antibodies in transplantation rejection |
| 09/01/2004 | EP0634936B1 Methods for immunocontraception |
| 09/01/2004 | EP0610254B1 Glial derived neurotrophic factor |
| 09/01/2004 | CN1526025A Genes expressed in breast cancer as prognostic and therapeutic targets |
| 09/01/2004 | CN1526020A Di- or oligomer of a dimer, trimer, quatrometer or pentamer of recombinant fusion proteins. |
| 09/01/2004 | CN1526018A Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/01/2004 | CN1526017A Gene associated with leishmania parasite virulence |
| 09/01/2004 | CN1526016A Method for stabilization of nucleic acids |
| 09/01/2004 | CN1526012A A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 09/01/2004 | CN1526011A Inhibition of apoptosis process and improvement of cell performance |
| 09/01/2004 | CN1525871A Nasal delivery devices |
| 09/01/2004 | CN1525869A Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
| 09/01/2004 | CN1525868A Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 09/01/2004 | CN1525864A Mucin peptide with immunoenhancing properties |
| 09/01/2004 | CN1525862A Novel receptors for dollar i(helicobacter pylori) and use thereof |
| 09/01/2004 | CN1525168A Methods of detecting alzheimer's disease |
| 09/01/2004 | CN1524950A Bacterial strain for preparing high efficiency capsule glycoprotein immunomodulator, screening and application thereof |
| 09/01/2004 | CN1524583A Use of gene for expressing Notch-ligand in production of medicinal preparations for immunotherapy |
| 09/01/2004 | CN1524575A Virulence genes and proteins, and their use |
| 09/01/2004 | CN1164616C Recombinant hepatitis B virus immune globulin |
| 09/01/2004 | CN1164332C Preparation method of horse SARS-resisting serum |
| 09/01/2004 | CN1164331C Human hepatitis B nucleic acid vaccine |
| 09/01/2004 | CN1164330C Genetically engineered rabies virus vaccine with recombination-defective adenovirus carrier |
| 08/31/2004 | US6784164 Choline binding proteins for anti-pneumococcal vaccines |
| 08/31/2004 | US6784155 Contacting hematopoietic cells with a stem cell proliferation stimulating amount of inprol or an opiate compound or a combination of inprol and an opiate compound |
| 08/31/2004 | US6783985 Identification of antifungal drug target genes; strain of diploid fungal cells in which both alleles of a gene are modified |
| 08/31/2004 | US6783960 Polypeptide for use in the treatment of thrombosis and sepsis |
| 08/31/2004 | US6783956 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |
| 08/31/2004 | US6783939 Alphavirus vectors and virosomes with modified HIV genes for use in vaccines |
| 08/31/2004 | US6783936 Antigenic epitopes with Lym-1 reactivity and uses thereof |
| 08/31/2004 | US6783765 Process for the preparation of a vaccine for the treatment of tuberculosis and other intracellular infections diseases and the vaccine produced by the process |
| 08/31/2004 | US6783764 Comprising purified apxiv toxin and a pharmaceutically acceptable carrier |
| 08/31/2004 | US6783763 Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines |
| 08/31/2004 | US6783762 Product and method for obtaining specific immunization with one or more antigens |
| 08/31/2004 | US6783761 Hormone inhibitors for inducing antibodies against gonadotropin-releasing hormone, comprises fusion peptide of helper t-cell peptide epitope and immunomimic peptide epitope |
| 08/31/2004 | US6783760 Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 08/31/2004 | US6783759 Compositions and methods for modulating variola virus |
| 08/31/2004 | US6783758 Diagnosis and treatment of malignant neoplasms |
| 08/31/2004 | CA2194369C Methods and compositions for the specific coagulation of vasculature |
| 08/28/2004 | CA2421086A1 Chicken rna polymerase i promoter and its use |
| 08/26/2004 | WO2004072651A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 1f receptor (5-ht1f) |
| 08/26/2004 | WO2004072296A2 Compositions for modulating immune cell activity and methods for detection thereof |
| 08/26/2004 | WO2004072287A1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 08/26/2004 | WO2004072274A1 Virus-like particle vaccine containing dengue virus recombinant replicon as its carrier |
| 08/26/2004 | WO2004072263A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | WO2004072262A2 Cultured cd14+ antigen presenting cells |
| 08/26/2004 | WO2004072257A2 Dyrks as modifiers of the apc and axin pathways and methods of use |
| 08/26/2004 | WO2004072233A2 Hiv-specific fusion proteins and therapeutic and diagnostic methods for use |
| 08/26/2004 | WO2004072095A2 Cyclized peptides as exotoxin antagonists |
| 08/26/2004 | WO2004071538A2 Topical delivery of cosmetic agents |
| 08/26/2004 | WO2004071529A2 Uses of anti-insulin-like growth factor i receptor antibodies |
| 08/26/2004 | WO2004071528A1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 08/26/2004 | WO2004071527A1 New pharmaceutical compositions based on anticholinergics and anti-tnf antibodies |
| 08/26/2004 | WO2004071518A1 Remedy for cancer |
| 08/26/2004 | WO2004071492A1 Virosome-like-particles |
| 08/26/2004 | WO2004071468A2 Short immunomodulatory oligonucleotides |
| 08/26/2004 | WO2004071458A2 REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS |
| 08/26/2004 | WO2004071457A2 Improved heat shock protein-based vaccines and immunotherapies |
| 08/26/2004 | WO2004071446A2 Immune complexes |
| 08/26/2004 | WO2004071441A2 Compositions and methods to modulate immune and inflammatory responses |
| 08/26/2004 | WO2004071439A2 Immunoglobulin formulation and method of preparation thereof |
| 08/26/2004 | WO2004071436A2 The use of gcc ligands |
| 08/26/2004 | WO2004071422A2 Streptococcal serum opacity factors and fibronectin-binding proteins and peptides thereof for the treatment and detection of streptococcal infection |
| 08/26/2004 | WO2004071414A2 Therapeutic anti-hcv (al9) compounds |
| 08/26/2004 | WO2004071411A2 Methods and compositions in treating pain and painful disorders using 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620 |
| 08/26/2004 | WO2004071405A2 Lactate dehydrogenase: a target and reagent for diabetes therapy |
| 08/26/2004 | WO2004071404A2 Use of il-6 antagonists in combination with steroids to enhance apoptosis |
| 08/26/2004 | WO2004071387A2 Hsp60 from arthrobacter |
| 08/26/2004 | WO2004052236A3 Methods and compositions for treatment of otitis media |
| 08/26/2004 | WO2004045555A3 Immunogenic epitopes for fibroblast growth factor 5 (fgf-5) presented by hla-a3 and hla-a2 |
| 08/26/2004 | WO2004045529A3 West nile virus vaccine |
| 08/26/2004 | WO2004044163A9 Methods for identifying risk of melanoma and treatments thereof |
| 08/26/2004 | WO2004035609A3 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions. |
| 08/26/2004 | WO2004031356A3 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 08/26/2004 | WO2004026024B1 Vaccine compositions and adjuvant |
| 08/26/2004 | WO2004022724A3 Adoptive transfer and uses thereof |
| 08/26/2004 | WO2004018684A3 T-cell epitopes in staphylococcal enterotoxin b |
| 08/26/2004 | WO2004002431A3 Humanized anti-lymphotoyin beta receptor antibodies |
| 08/26/2004 | WO2003101397A3 Tetravalent dengue vaccines |
| 08/26/2004 | WO2003092602A3 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/26/2004 | WO2003077859A3 Method of inducing an enhanced immune response against hiv |
| 08/26/2004 | WO2003061519A3 Methods and compositions for preserving the viability of photoreceptor cells |
| 08/26/2004 | WO2003055440A3 Compositions and methods for the treatement of immune related diseases |
| 08/26/2004 | WO2002102320A3 Fce fusion proteins for treatment of allergy and asthma |
| 08/26/2004 | WO2002044334A3 Recombinant rsv virus expression systems and vaccines |
| 08/26/2004 | US20040167202 Induction of immune tolerance |
| 08/26/2004 | US20040167091 Methods for treating ocular neovascular diseases |
| 08/26/2004 | US20040167089 Immunostimulatory nucleic acid molecules |
| 08/26/2004 | US20040167075 Diagnosis, therapy od Alzheimer's disease; blocking psychological conditions |
| 08/26/2004 | US20040167068 Neisseria ORF2086 proteins; immunogenic compositions that elicit bactericidal antibodies to multiple neisserial strains; react with the surface of multiple strains; confer passive protection against a live challenge; and/or prevent colonization. |
| 08/26/2004 | US20040167066 Cleavage and polyadenylation complex of precursor mrna |
| 08/26/2004 | US20040167065 human transferases and polynucleotides which identify and encode them; expression vectors, host cells, antibodies, agonists, and antagonists; diagnosing, treating, or preventing disorders associated with aberrant expression of the transferases |
| 08/26/2004 | US20040167060 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 08/26/2004 | US20040166527 Compositions and methods for the identification of lung tumor cells |
| 08/26/2004 | US20040166517 Diagnosing breast cancer via presence of sulphate transporter proteins; antitumor agents |
| 08/26/2004 | US20040166141 Methods and devices for modulating the immune response |
| 08/26/2004 | US20040166123 Allergen dosage form |
| 08/26/2004 | US20040166122 Adenovirus formulations |
| 08/26/2004 | US20040166121 Viricides from transgenic plant; dna sequences codes gene expression on surface of antigen ; insertion of nucleotide sequence into plant; genetic engineering |